148 related articles for article (PubMed ID: 2412918)
1. Prevention of defective axonal transport in streptozocin-diabetic rats by treatment with "Statil" (ICI 128436), an aldose reductase inhibitor.
Tomlinson DR; Townsend J; Fretten P
Diabetes; 1985 Oct; 34(10):970-2. PubMed ID: 2412918
[TBL] [Abstract][Full Text] [Related]
2. Reduced anterograde and retrograde accumulation of axonally transported phosphofructokinase in streptozotocin-diabetic rats: effects of insulin and the aldose reductase inhibitor 'Statil'.
Willars GB; Calcutt NA; Tomlinson DR
Diabetologia; 1987 Apr; 30(4):239-43. PubMed ID: 2439402
[TBL] [Abstract][Full Text] [Related]
3. Slow component-a of axonal transport, nerve myo-inositol, and aldose reductase inhibition in streptozocin-diabetic rats.
Tomlinson DR; Sidenius P; Larsen JR
Diabetes; 1986 Apr; 35(4):398-402. PubMed ID: 2420664
[TBL] [Abstract][Full Text] [Related]
4. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition.
Whiteley SJ; Townsend J; Tomlinson DR; Willars GB
Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444
[TBL] [Abstract][Full Text] [Related]
5. Prevention of defects of axonal transport and nerve conduction velocity by oral administration of myo-inositol or an aldose reductase inhibitor in streptozotocin-diabetic rats.
Mayer JH; Tomlinson DR
Diabetologia; 1983 Nov; 25(5):433-8. PubMed ID: 6197336
[TBL] [Abstract][Full Text] [Related]
6. Axonal transport and tissue contents of substance P in rats with long-term streptozotocin-diabetes. Effects of the aldose reductase inhibitor 'statil'.
Robinson JP; Willars GB; Tomlinson DR; Keen P
Brain Res; 1987 Nov; 426(2):339-48. PubMed ID: 2446712
[TBL] [Abstract][Full Text] [Related]
7. Studies on peripheral nerve and lens in long-term experimental diabetes: effects of the aldose reductase inhibitor statil.
Willars GB; Townsend J; Tomlinson DR; Compton AM; Churchill RD
Metabolism; 1988 May; 37(5):442-9. PubMed ID: 2452959
[TBL] [Abstract][Full Text] [Related]
8. Treatment with an aldose reductase inhibitor can reduce the susceptibility of fast axonal transport following nerve compression in the streptozotocin-diabetic rat.
Dahlin LB; Archer DR; McLean WG
Diabetologia; 1987 Jun; 30(6):414-8. PubMed ID: 2445613
[TBL] [Abstract][Full Text] [Related]
9. Slow orthograde axonal transport of radiolabelled protein in sciatic motoneurones of rats with short-term experimental diabetes: effects of treatment with an aldose reductase inhibitor or myo-inositol.
Mayer JH; Tomlinson DR; McLean WG
J Neurochem; 1984 Nov; 43(5):1265-70. PubMed ID: 6208327
[TBL] [Abstract][Full Text] [Related]
10. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
Tomlinson DR; Moriarty RJ; Mayer JH
Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
[TBL] [Abstract][Full Text] [Related]
11. Reversal of deficits in axonal transport and nerve conduction velocity by treatment of streptozotocin-diabetic rats with myo-inositol.
Tomlinson DR; Mayer JH
Exp Neurol; 1985 Aug; 89(2):420-7. PubMed ID: 2410289
[TBL] [Abstract][Full Text] [Related]
12. The effect of aldose reductase inhibitor Statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats.
Sochor M; Kunjara S; McLean P
Biochem Pharmacol; 1988 Sep; 37(17):3349-56. PubMed ID: 2969732
[TBL] [Abstract][Full Text] [Related]
13. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
Stribling D; Mirrlees DJ; Harrison HE; Earl DC
Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
[TBL] [Abstract][Full Text] [Related]
14. The effect of aldose reductase inhibition on the pattern of nerve conduction deficits in diabetic rats.
Cameron NE; Cotter MA; Robertson S
Q J Exp Physiol; 1989 Nov; 74(6):917-26. PubMed ID: 2512591
[TBL] [Abstract][Full Text] [Related]
15. Studies of sorbinil on axonal transport in streptozotocin-diabetic rats.
Willars GB; Tomlinson DR; Robinson JP
Metabolism; 1986 Apr; 35(4 Suppl 1):66-70. PubMed ID: 2421136
[TBL] [Abstract][Full Text] [Related]
16. Statil-sensitive polyol formation in nerve of galactose-fed mice.
Calcutt NA; Willars GB; Tomlinson DR
Metabolism; 1988 May; 37(5):450-3. PubMed ID: 3130544
[TBL] [Abstract][Full Text] [Related]
17. Defects of axonal transport in experimental diabetes that are unrelated to the sorbitol pathway.
Tomlinson DR; Willars GB; Calthrop-Owen EF
Exp Neurol; 1987 Apr; 96(1):194-202. PubMed ID: 2435570
[TBL] [Abstract][Full Text] [Related]
18. Prevention of defects of axonal transport in experimental diabetes by aldose reductase inhibitors.
Tomlinson DR; Willars GB; Robinson JP
Drugs; 1986; 32 Suppl 2():15-8. PubMed ID: 2431858
[TBL] [Abstract][Full Text] [Related]
19. Sorbitol metabolism in the retina, optic nerve, and sural nerve of diabetic rats treated with an aldose reductase inhibitor.
Naeser P; Brolin SE; Eriksson UJ
Metabolism; 1988 Dec; 37(12):1143-5. PubMed ID: 3143049
[TBL] [Abstract][Full Text] [Related]
20. A combination of the aldose reductase inhibitor, statil, and the prostaglandin E1 analogue, OP1206.alpha CD, completely improves sciatic motor nerve conduction velocity in streptozocin-induced chronically diabetic rats.
Yasuda H; Sonobe M; Hisanaga T; Kawabata T; Maeda K; Kikkawa R; Shigeta Y
Metabolism; 1992 Jul; 41(7):778-82. PubMed ID: 1320179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
